lutetium lu 177 vipivotide tetraxetan
novartis
['gu ', 'crpc', 'pluvicto']
#asco22 gu oncologists -- i'm genuinely curious about experiences accessing #pluvicto for #psma positive patients with #mcrpc in real-world setting. dms open!
Health & science journalist ???Biopharma reporter @PrecOncNews @GenomeWeb?Past: @ASCO, @ColumbiaJourn?I cover cancer treatment??, genomics??, + sometimes ??s